Antineoplastic and cytogenetic effects of platinum(II) and palladium(II) complexes with pyridine-2-carboxyaldehyde-thiosemicarbazone

Chemotherapy

Volumn 44, Issue 6, 1998, Pages 421-426

  Kovala Demertzi, D ^a   Demertzis, M A ^a   Varagi, V ^a   Papageorgiou, A ^b   Mourelatos, D ^b   Mioglou, E ^b   Iakovidou, Z ^b   Kotsis, A ^b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Antileukemic activity; Cell kinetics; Platinum(II) and palladium(II) complexes; Pyridine 2 carboxyaldehyde thiosemicarbazone; Sister chromatid exchanges

Indexed keywords

PALLADIUM COMPLEX; PLATINUM COMPLEX; PYRIDINE 2 CARBOXYALDEHYDE THIOSEMICARBAZONE; THIOSEMICARBAZONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKEMIA P 388; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; PRIORITY JOURNAL; SISTER CHROMATID EXCHANGE;

ANIMALS; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; LEUKEMIA P388; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; ORGANOMETALLIC COMPOUNDS; ORGANOPLATINUM COMPOUNDS; PALLADIUM; SISTER CHROMATID EXCHANGE; THIOSEMICARBAZONES;

EID: 0031668822     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007154     Document Type: Article

References (18)

1. Liberia AE, West DX: Antifungal and antitumour activity of heterocyclic thiosemicarbazones and their metal complexes. Biometals 1992;5: 121-126.
2. French FA, Blanz JE: a-(N)-Formylheteroaromatic thiosemicarbazones. Inhibition of tumour-derived ribonucleoside diphosphate reductase and correlation with in vivo antitumour activity. J Med Chem 1974;17:172-181.
3. Hemmerich P, Prijs B, Erlenmeyer H: Pyridyl-1,3,4-Thiadiazol; eine neue Variante der thiadiazol-Synthese. Helv Chim Acta 1958;217: 2059-2065.
4. Dodd RH, Ouannes C, Robert-Gero M, Potier P: Hybrid molecules: Growth inhibition of Leishmania donovani promastigotes by thiosemicarbazones of 3-carboxy-β-carbolines. J Med Chem 1989;321272-1276.
5. Mignot A, Miocque M, Binet P, Rapin J-R, Rinjard P: Thiosemicarbazones of aromatic aldehydes as antiinflammatory agents: pharmacology preliminary pharmacokinetic study, effect on fibroblasts in culture. Eur J Med Chem 1980;15:33-40.
6. Kovala-Demertzi D, Domopoulou A, Demertzis MA, Raptopoulou CP, Terzis A: Coordinating properties of 2-acetylpyridine thiosemicarbazone. palladium(II) complexes with neutral and deprotonated ligand. X-ray structure of bromo (2-acetylpyridine thiosemicarbazonato) palladium(II). Polyhedron 1994;13: 1917-1925.
7. Kovala-Demertzi D, Domopoulou A, Demertzis MA, Valdes-Martinez J, Espinosa-Perez G, West DX, Salberg MM, Bain GA, Bloom PB: Structures and spectral properties of palladium(II) complexes of 2-acetylpyridine N(4)-dimethylthiosemicarbazone. Polyhedron 1996;15:2587-2596.
8. Kovala-Demertzi D, Domopoulou A, Demertzis MA: Synthesis, spectroscopy and structures of complexes of PD(II) with 4N-substituted derivatives of 2-acetylpyridine thiosemicarbazone. Cytotoxic, Mutagenic and Carcinogenic Potential of Heavy Metals Related to Human Environment, Lucznik, Przesieka, June 1996; in Hadjiliadis ND (ed): Nato ASI Series. Dordrecht, Kluwer, 1996, pp 467-476.
9. Kovala-Demertzi D, Domopoulou A, Demertzis MA, Papageorgiou A, West DX: Palladium(II) complexes of 2-acetylpyridine N(4)-propyl, N(4)-dipropyl-, and 3-hexamethyleiminylthiosemicarbazones with potentially interesting biological activity. Synthesis, physico-chemical properties, antifungal and in vitro antitumour Activity. Polyhedron 1997;16:3625-3633.
10. Kovala-Demertzi D, Domopoulou A, Demertzis MA, Valle G, Papageorgiou A: Palladium(II) complexes of 4N-methyl and 4N-ethyl and 4N-phenyl 2-acetylpyridine thiosemicarbazones. Crystal structure of chloro(4N-methyl-2-actylpyridine thiosemicarbazonato)palladium(II). Synthesis, chemico-physical study, in vitro and in vivo antitumour activity. J Inorg Biochem 1997;68:147-157.
11. Papageorgiou A, lakovidou Z, Mourelatos D, Mioglou E, Boutis L, Kotsis A, Kovala-Demertzi D, Domopoulou A, West DX, Demertzis M: Antineoplastic and cytogenetic effects of complexes of Pd(II) with 4N-substituted derivatives of 2-acetylpyridine-thiosemicarbazone. Anticancer Res 1997;17:247-253.
12. Tofilon PJ, Basic I, Milas L: Prediction of in vivo tumour response to the chemotherapeutic agents by the in vitro sister chromatid exchange assay. Cancer Res 1985;45:2025-2030.
13. Eliopoulos P, Mourelatos D, Dozi-Vassiliades J: Comparative study on Salmonella mutagenicity and on cytogenetic and antineoplastic effects induced by cyclophosphamide and 3-aminobenzamide in cells of three transplantable tumours in vivo. Mutat Res 1995;343:141-146.
14. Mourelatos D, Dozi-Vassiliades J, Kotsis A, Gourtsas C: Enhancement of cytogenetic damage and of antineoplastic effect by caffeine in Ehrlich ascites tumour cell treated with cyclophosphamide in vivo. Cancer Res 1988;48:1129-1131.
15. Deen DF, Kendall LE, Marton LJ, Tofilon PJ: Prediction of tumour cell chemosensitivity using the sister chromatid exchange assay. Cancer Res 1986;46:1599-1602.
16. Goldin A, Sofina Z, Syrkin A: Experimental evaluation of antitumor drugs in the USA and USSR and clinical correlations. Nat Cancer Inst Monogr 1980;55.
17. Gaudin D, Yieldin KL: Response of a resistant plasmacytoma to alkylating agent and X-ray in combination with excision repair inhibitors caffeine and chloroquine. Proc Soc Exp Biol Med 1969;131:1413-1416.
18. Kihlman BA: Caffeine and Chromosomes. Amsterdam, Elsevier, 1977, pp 153-246.